Share on StockTwits

Lumenis’ (NASDAQ:LMNS) lock-up period will expire on Tuesday, August 26th. Lumenis had issued 6,250,000 shares in its public offering on February 27th, Stock Ratings News reports. The total size of the offering was $75,000,000 based on an initial share price of $12.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of Lumenis (NASDAQ:LMNS) traded down 0.44% during mid-day trading on Thursday, hitting $9.02. 373 shares of the company’s stock traded hands. Lumenis has a one year low of $8.16 and a one year high of $13.38. The stock’s 50-day moving average is $9.35 and its 200-day moving average is $9.80. The company has a market cap of $321.1 million and a price-to-earnings ratio of 35.25.

Lumenis (NASDAQ:LMNS) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.11 by $0.02. The company had revenue of $72.50 million for the quarter, compared to the consensus estimate of $70.30 million. Lumenis’s revenue was up 9.4% compared to the same quarter last year. Analysts expect that Lumenis will post $0.53 EPS for the current fiscal year.

Lumenis Ltd. is a provider of energy-based, minimally invasive clinical solutions. The Company operated in three segments: surgical, ophthalmic and aesthetic.

Receive News & Ratings for Lumenis Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumenis Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.